Items where Author or Contributor is "Baxter, L"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Year | Item Type | Full Text
Jump to: 2013 | 2012 | 2011 | 2010 | 2009 | 2007
Number of items: 12.

2013

Shepherd, J; Jones, J; Frampton, G; Bryant, J; Baxter, L; Cooper, K; (2013) Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation. Health technology assessment (Winchester, England), 17 (34). pp. 1-264. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta17340
[img]

2012

Hartwell, D; Jones, J; Baxter, L; Shepherd, J; (2012) Shortened peginterferon and ribavirin treatment for chronic hepatitis C. International journal of technology assessment in health care, 28 (4). pp. 398-406. ISSN 0266-4623 DOI: https://doi.org/10.1017/S0266462312000463
[img]

2011

2010

Takeda, A; Cooper, K; Bird, A; Baxter, L; Frampton, GK; Gospodarevskaya, E; Welch, K; Bryant, J; (2010) Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 14 (42). 1-209, iii-iv. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta14420
[img]

2009

Bryant, J; Baxter, L; Hird, S; (2009) Non-occupational postexposure prophylaxis for HIV: a systematic review. Health technology assessment (Winchester, England), 13 (14). iii, ix-x, 1-60. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta13140
[img]

Jones, J; Shepherd, J; Baxter, L; Gospodarevskaya, E; Hartwell, D; Harris, P; Price, A; (2009) Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation. Health technology assessment (Winchester, England), 13 (35). 1-172, iii. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta13350
[img]

Picot, J; Jones, J; Colquitt, JL; Gospodarevskaya, E; Loveman, E; Baxter, L; Clegg, AJ; (2009) The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 13 (41). 1-190, 215-357, iii-iv. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta13410
[img]

2007

Baxter, L; Bryant, J; Cave, CB; Milne, R; (2007) Recombinant growth hormone for children and adolescents with Turner syndrome. The Cochrane database of systematic reviews (1). CD003887. ISSN 1469-493X DOI: https://doi.org/10.1002/14651858.CD003887.pub2
[img]

Bryant, J; Baxter, L; Cave, CB; Milne, R; (2007) Recombinant growth hormone for idiopathic short stature in children and adolescents. The Cochrane database of systematic reviews (3). CD004440. ISSN 1469-493X DOI: https://doi.org/10.1002/14651858.CD004440.pub2
[img]

Bryant, J; Picot, J; Baxter, L; Levitt, G; Sullivan, I; Clegg, A; (2007) Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. British journal of cancer, 96 (2). pp. 226-30. ISSN 0007-0920 DOI: https://doi.org/10.1038/sj.bjc.6603562
[img]

Bryant, J; Picot, J; Baxter, L; Levitt, G; Sullivan, I; Clegg, A; (2007) Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. European journal of cancer (Oxford, England, 43 (13). pp. 1959-66. ISSN 0959-8049 DOI: https://doi.org/10.1016/j.ejca.2007.06.012 Full text not available from this repository.

Bryant, J; Picot, J; Levitt, G; Sullivan, I; Baxter, L; Clegg, A; (2007) Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Health technology assessment (Winchester, England), 11 (27). iii, ix-x, 1-84. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta11270
[img]

This list was generated on Fri Feb 28 06:42:59 2020 GMT.